Therapeutic Solutions International Inc (TSOI)

[doogdilinger]

Updated TSOI full DD packet as of Friday September 3rd for those just getting started on their due here! TSOI is a fully registered SEC Reporting filer, which means they file fully audited financials and subscribe to OTC Markets Green Shield verified direct from the Transfer Agent Share Structure program:





https://www.otcmarkets.com/stock/TSOI/profile



And here's the entire ALL STAR team of career big board established executives already with their name on TSOI's door alongside our scientist CEO folks:

Timothy G. Dixon – President, CEO, & Chairman

Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies:
https://therapeuticsolutionsint.com/management/




TSOI CEO Dixon's shareholder education forum:

https://board.therapeuticsolutionsint.com/viewforum.php?f=2&sid=13a8f36abaf3ea8212c019779ed0955c






Thomas Ichim PHD:
https://www.marketscreener.com/business-leaders/Thomas-Ichim-074P9M-E/biography/




FRANCESCO MARINCOLA, MD:
https://www.kitepharma.com/about-us/leadership/kite-leadership-list/francesco-marincola

Santosh Kesari, MD, PHD:
https://www.saintjohnscancer.org/about-us/people/santosh-kesari/

Vijay Mahant MD:
https://www.biospace.com/article/releases/oncology-pharma-appoints-dr-vijay-mahant-as-the-chief-scientific-officer-and-chief-operating-officer/

David P. Hajjar MD:
https://www.brookings.edu/experts/david-p-hajjar/

Boris Minev MD:
https://eutranslationalmedicine.org/boris-minev

Pablo Guzman MD:
https://www.doximity.com/pub/pablo-guzman-md-eb4cae80

Juergen Winkler, MD:
https://www.qfmed.com/

Nassir Azimi, MD:
https://www.sharp.com/san-diego-doctors/dr-nassir-azimi-71718

James Veltmeyer MD:
https://drveltmeyer.com/meet-dr-veltmeyer/

Barry Glassman, DMD:
https://therapeuticsolutionsint.com/CV/Barry_Glassman_CV.pdf

Feng Lin MD PHD:
https://profils-profiles.science.gc.ca/en/profile/dr-feng-lin-phd

Hong Ma, MD, PHD, MBA:
https://biography.omicsonline.org/united-states-of-america/batu-biologics-inc/hong-ma-md-phd-mba-1758889

Howard Leonhardt:
https://leonhardtventures.com/howard-leonhardt/

J. Christopher Mizer:
https://www.vivariscapital.com/executive-team

Boris Reznik:
https://en.wikialpha.org/wiki/Boris_Reznik

Peter Farrel PHD:
https://www.webmd.com/peter-c-farrell

Francisco Silva:
Mr. Silva previously served as Chief Executive Officer of two companies engaged in the commercialization of human-based biologics for both research and therapeutic applications. Mr. Silva is the inventor of numerous game-changing technologies in the area of regenerative medicine. His work at PrimeGen was the precursor to the Nobel Prize winning iPSC technology, as well as his subsequent co-discovery of two unique stem cell sources.
https://www.bloomberg.com/profile/person/17243529
https://www.biorestorative.com/




Bio's to all the above TSOI executive mgmt roster and scientific advisory board below:

https://therapeuticsolutionsint.com/management/

https://therapeuticsolutionsint.com/scientific-advisory-board/



TSOI's entire IP pipeline filed to date:

https://therapeuticsolutionsint.com/patent-abstracts/



TSOI CEO Dixon's shareholder education forum:

https://board.therapeuticsolutionsint.com/viewforum.php?f=2&sid=13a8f36abaf3ea8212c019779ed0955c


And here's TSOI's Immunotherapies & Product Indication List updated for us from our resident TSOI ihub forum DD expert, the poster centsability as of 8/23/21:


https://board.therapeuticsolutionsint.com/viewtopic.php?f=2&t=54


Stage 1 - 4 Cancers (Tumor types) - Breast Cancer , Prostate Cancer w/ StemVacs Immunotherapy Platform https://stemvacs.com/ , BRS-001 https://www.globenewswire.com/news-release/2018/06/11/1519648/0/en/Therapeutic-Solutions-International-Expands-Adoptive-Immunotherapy-Portfolio-by-Incorporation-of-Universal-Cancer-Antigen-into-StemVacs-Dendritic-Cell-Platform.html, NanoStilbeneTM , https://mynanostilbene.com/
Cancer Metabolic DeTox, https://www.globenewswire.com/news-release/2017/05/09/1076506/0/en/Therapeutic-Solutions-files-new-Patent-on-Targeting-the-Tumor-Microenvironment-through-Nutraceutical-Based-Immunoadjuvants.html
and IsoStilbene https://www.globenewswire.com/news-release/2018/06/25/1529010/0/en/Therapeutic-Solutions-International-Releases-IsoStilbene-Injectable-Formulation-of-Pterostilbene-Under-Granted-Patent-for-Augmentation-of-Immunotherapy-and-Targeting-of-Cancer-Stem.html
Liver Cancer, Esophageal Cancer, Melanoma (w/ Ipilimumab) and NanoStilbene (As an adjuvant), https://www.globenewswire.com/news-release/2019/07/22/1885810/0/en/Therapeutic-Solutions-International-Reports-its-NanoStilbene-Nutraceutical-Product-Enhances-Efficacy-of-FDA-Cleared-Cancer-Immunotherapy-in-Animal-Model-of-Cancer.html
Breast Cancer, Prostate Cancer, and Ovarian Cancer w/ Ozone therapy , and NanoStilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2018/08/13/1550904/0/en/Therapeutic-Solutions-International-Reports-Synergistic-Enhancement-of-Ozone-Therapy-Efficacy-in-Prostate-Breast-and-Ovarian-Cancer-Cells-by-Pterostilbene.html
Prostate Cancer w/ NanoPSA https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html
and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html
Glioma / Brain Cancers w/ NeuroStilbene , and Brain Cancer Therapeutics https://www.globenewswire.com/news-release/2018/07/16/1537652/0/en/Therapeutic-Solutions-International-Inc-Releases-Intranasal-Formulation-of-Pterostilbene-for-Rapid-Access-to-Blood-Brain-Barrier.html
The Root of Cancer w/ StemVacs "Killer T Cells" (Personalized Adoptive T Cell Therapy)- including T cells capable of killing glioma, leukemia, and mastocytoma https://www.prnewswire.com/news-releases/therapeutic-solutions-international-uses-stemvacs-platform-to-generate-personalized-adoptive-t-cell-therapy-targeting-cancer-stem-cells-301232543.html
Cancer Tumor Blood Vessel Targeting w/ StemVacs (Dendritic Cell based Immunotherapy) https://board.therapeuticsolutionsint.com/viewtopic.php?f=17&t=552
Choking Cancer Blood Vessels w/ TSOI Hybrid Chimeric Cell (fusing StemVacs-V with iPSC derived endothelial cells) https://www.prnewswire.com/news-releases/therapeutic-solutions-international-creates-hybrid-cell-designed-to-educate-immune-system-to-choke-cancer-blood-vessels-301253715.html
Cancer w/ StemVacs - V "Super-Killers" Combining iPSC - (Inducible Pluripotent Stem Cell) Technology with Gene Silencing and NIH Discovered Universal Tumor Antigen https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-novel-cancer-resistant-ipsc-derived-dendritic-cell-immunotherapy-stemvacs-v-301248331.html
Cancer w/ StemVacs - V AG (Alpha Gal) https://www.prnewswire.com/news-releases/therapeutic-solutions-international-demonstrates-potent-and-selective-destruction-of-tumor-blood-vessels-by-leveraging-pre-existing-natural-anti-xenogeneic-antibodies-301257387.html
Cancer Tumor Endothelial Targeting w/ StemVacs - V iPSC & Optimized immunological adjuvants https://www.prnewswire.com/news-releases/therapeutic-solutions-international-optimizes-targeting-the-achilles-heel-of-cancer-using-second-generation-tumor-endothelial-targeting-vaccine-stemvacs-v-ipsc-301297580.html
Cancer w/ StemVacs-V iPSC & Other Immunotherapies such as CAR-T therapies, or tumor specific therapeutic vaccines https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-amplification-of-cancer-specific-immune-responses-using-second-generation-tumor-endothelial-targeting-vaccine-stemvacs-v-ipsc-301306771.html
Cancer w/ Cyclophosphamide , and NanoStilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2019/07/29/1892915/0/en/NanoStilbene-Nutraceutical-Shown-to-Increase-Ability-of-Cyclophosphamide-Chemotherapy-to-Suppress-Cancer.html
Cancer w/ Ipilimumab (Yervoy® - A checkpoint Inhibitor), and NanoStilbene (As an adjuvant) https://www.globenewswire.com/news-release/2019/07/22/1885810/0/en/Therapeutic-Solutions-International-Reports-its-NanoStilbene-Nutraceutical-Product-Enhances-Efficacy-of-FDA-Cleared-Cancer-Immunotherapy-in-Animal-Model-of-Cancer.html
Cancer w/ Herceptin (A Monoclonal Antibody), and Nanostilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2019/08/26/1906525/0/en/Therapeutic-Solutions-International-Announces-Positive-Clinical-Data-Using-NanoStilbene-to-Stimulate-Immune-System-in-Advanced-Cancer-Patients.html ,
Cancer w/ Rituximab , or Cetuximab , and NanoStilbene (As an adjuvant) https://www.globenewswire.com/news-release/2016/07/11/1076482/0/en/Therapeutic-Solutions-International-Reports-Augmentation-of-Cancer-Immunotherapy-Using-Pterostilbene.html
Melanoma, Glioma, and Lung Cancer w/ StemVacs-V iPSC, and cyclophosphamide https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-regression-of-established-tumors-by-combining-its-cancer-blood-vessel-targeting-immunotherapy-with-low-dose-chemotherapy-301276645.html



CTE / Military and Sports Brain Injuries - (Chronic Traumatic Encephalopathy) w/ JadiCell MSCs (Mesenchymal Stem Cells) https://www.globenewswire.com/news-release/2019/07/01/1876699/0/en/Therapeutic-Solutions-International-Obtains-Exclusive-License-for-Patented-Clinical-Stage-Adult-Stem-Cell-for-Treatment-of-Military-and-Sports-Brain-Injuries.html ,
Autologous Neurogenic Stem Cell Banking, https://www.globenewswire.com/news-release/2019/01/09/1682934/0/en/Therapeutic-Solutions-International-Continues-to-Expand-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
sRNA augmented stem cells, https://www.globenewswire.com/news-release/2018/12/06/1663162/0/en/Therapeutic-Solutions-International-Expands-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
"Educated" Monocytes / Progenitors, https://www.globenewswire.com/news-release/2019/01/22/1703514/0/en/Therapeutic-Solutions-International-Continues-to-Expand-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
and NeuroStilbene https://www.globenewswire.com/news-release/2018/10/25/1627211/0/en/Therapeutic-Solutions-International-Announces-CTE-Optimized-NeuroStilbene-Formulation.html
TBI / mTBI / bTBI (blast TBI) - (Traumatic Brain Injury / mild TBI) w/ JadiCell MSCs, https://www.globenewswire.com/news-release/2019/07/01/1876699/0/en/Therapeutic-Solutions-International-Obtains-Exclusive-License-for-Patented-Clinical-Stage-Adult-Stem-Cell-for-Treatment-of-Military-and-Sports-Brain-Injuries.html
and NeuroStilbene https://www.globenewswire.com/news-release/2018/07/16/1537652/0/en/Therapeutic-Solutions-International-Inc-Releases-Intranasal-Formulation-of-Pterostilbene-for-Rapid-Access-to-Blood-Brain-Barrier.html

CRS - (Cytokine Release Syndrome) / Inflammation , Car-T sickness / Immunotherapy side effects w/ NanoStilbeneTM https://www.globenewswire.com/news-release/2018/09/25/1575802/0/en/Therapeutic-Solutions-International-Files-Patent-on-Clinical-Data-Demonstrating-Reduction-of-Inflammatory-Cytokines-Using-NanoStilbene.html


Diabetes, Cardiovascular Disease, and Neurodegenerative Diseases w/ Projuvenol ® https://www.globenewswire.com/news-release/2016/04/28/1076470/0/en/Therapeutic-Solutions-International-Files-Patent-Covering-ProJuvenol-C-and-Its-Active-Ingredient-Pterostilbene.html

Neurological Modulation w/ StemVacs & Homotaurine https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-enhancement-of-stemvacs-immune-stimulating-activity-using-neuromodulatory-compound-homotaurine-301215167.html
Neural Inflammation, Regeneration & Protection of Brain Cells w/ NeuroStilbene https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-inhibition-of-microglial-activation-with-neurostilbene-300983513.html
Neurodegenerative Conditions / Oxidative Brain and Neural Disorders - MS (Multiple Sclerosis), Stroke / post Stroke recovery, and Alzheimers, w/ Alpha Lipoic Acid https://www.globenewswire.com/news-release/2018/08/06/1547454/0/en/Therapeutic-Solutions-International-Develops-Microemulsion-Formulation-of-Alpha-Lipoic-Acid-for-Intranasal-Delivery.html
Neuroinflammation induced brain damage w/ JadiCell MSCs https://www.prnewswire.com/news-releases/therapeutic-solutions-international-demonstrates-potent-brain-protective-activity-of-jadicells-in-animal-model-of-post-covid-19-neurological-damage-301323081.html
MS (Multiple Sclerosis) w/ NanoStilbene https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-positive-preclinical-data-on-multiple-sclerosis--using-nanostilbene-301154733.html


Elevated PSA Levels w/ NanoPSA https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html
and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html

RA - (Rheumatoid Arthritis) / Synovitis w/ NanoPSA , https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html
and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html


TNF (Tumor Necrosis Factor) / Atherosclerosis / TF (Tissue Factor) Elevations, Sepsis, Cardiovascular Disease, RA , Infection w/ NanoStilbene PKE https://www.globenewswire.com/news-release/2019/02/19/1734360/0/en/Therapeutic-Solutions-International-Continues-to-Refine-NanoStilbene-Formulation.html



Covid 19, SARS, ARDS, Breast Cancer, RA, Depression w/ QuadraMune, https://quadramune.com/ ,https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-quadramune-reduces-myeloid-suppressor-cells-in-4t1-mouse-model-of-breast-cancer-301074437.html,
https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-preclinical-and-clinical-evaluation-of-nutritional-supplement-quadramune-designed-to-protect-against-covid-19-301070796.html , https://www.prnewswire.com/news-releases/therapeutic-solutions-international-division-of-campbell-neurosciences-files-patent-on-quadramune-for-treatment-of-major-depressive-disorder-301189517.html
and NLRP3 Trifecta https://www.youcanordernow.com/NLRP3-Trifecta-_p_33.html

Covid 19 w/ StemVacs 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-intention-to-use-clinical-stage-nk-activating-cancer-immunotherapy-for-covid-19-301081006.html

COPD w/ JadiCell MSCs, and various therapeutic combinations https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-preclinical-results-using-jadicells-in-animal-model-of-chronic-obstructive-pulmonary-failure-copd-301360477.html
Lung disease / ARDS w/ JadiCell MSCs https://www.prnewswire.com/news-releases/therapeutic-solutions-international-acquires-stem-cell-therapy-that-successfully-completed-fda-double-blind-placebo-controlled-efficacy-study-for-lung-disease-301225932.html

Covid 19 / Delta Variant w/ JadiCell MSCs and IL 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-identifies-and-files-patent-on-novel-mechanism-of-action-of-its-fda-phase-iii-cleared-jadicell-treatment-of-covid-19-and-delta-variant-301357756.html


Covid Damaged Lungs w/ Cord blood based immunotherapy https://www.prnewswire.com/news-releases/san-diego-top-doctor-james-veltmeyer-collaborates-with-therapeutic-solutions-international-in-cord-blood-based-immunotherapy-for-covid-19-damaged-lungs-301057622.html

Lung Scarring w/ JadiCell MSCs & lithium carbonate https://www.prnewswire.com/news-releases/therapeutic-solutions-international-develops-novel-stem-cell-based-therapy-to-reduce-lung-scarring-potential-solution-to-post-covid-19-lung-deterioration-301296796.html


Monocyte Immunotherapy for Suicide Prevention & Ideation - Brain inflammation https://www.prnewswire.com/news-releases/therapeutic-solutions-international-spin-off-campbell-neurosciences-announces-umbilical-cord-derived-monocyte-immunotherapy-candidate-for-suicide-prevention-301240517.html

Depression w/ IL-2 Therapy https://www.prnewswire.com/news-releases/therapeutic-solutions-international-and-campbell-neurosciences-announce-preclinical-studies-showing-low-doses-of-fda-cleared-immune-stimulant-interleukin-2-reduces-inflammation-associated-depression-in-animal-model-301292421.html

Schizophrenia w/ Jadicell MSCs, https://www.prnewswire.com/news-releases/therapeutic-solutions-international-files-comprehensive-campbell-platform-patent-for-stem-cell-immunotherapy-of-schizophrenia-301130078.html
and low dose naltrexone and agents stimulating T regulatory cells https://www.prnewswire.com/news-releases/campbell-neurosciences-spin-off-of-therapeutic-solutions-reports-synergistic-reduction-of-schizophrenia-in-animal-models-using-low-dose-naltrexone-and-t-regulatory-cell-stimulation-301313738.html


Opioid addiction w/ Neuroleukin, https://www.biospace.com/article/releases/therapeutic-solutions-international-files-patent-on-neuroleukin-personalized-immunotherapy-for-opioid-addiction/
and NarcoStem https://www.prnewswire.com/news-releases/therapeutic-solutions-international-spin-off-campbell-neurosciences-identifies-mechanism-of-action-for-umbilical-cord-blood-derived-narcostem-drug-rehabilitation-product-301271379.html

Anti - Aging w/ Cord Blood plasma, and NanoStilbene, https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-augmentation-of-rejuvenating-activity-of-cord-blood-plasma-by-pterostilbene-300950777.html
and Projuvenol https://www.youcanordernow.com/ProJuvenol-60-Capsule_p_12.html






All of TSOI's recent mind blowing FDA approval PR's & key board member additions over just the past 30 days alone:

https://finance.yahoo.com/quote/TSOI/press-releases?p=TSOI